Sean McCafferty is an Ophthalmology physician affiliated with University of Arizona. OpenAlex indexes 34 publications with 305 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6422 E Speedway Blvd Ste 100
Tucson, AZ 857101151
Telephone
520-327-3487Registry record last updated 31 Aug 2015.
Clinical trials
- Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
Sponsor: Intuor Technologies, Inc.
- Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines
Sponsor: Intuor Technologies, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20252 payments
- Apellis Pharmaceuticals, Inc.Program year20251 payment
- Tarsus Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
82.7%Prostaglandin Analog33.1%Latanoprost95%Lumigan3%Travoprost2%Part D<11 patientsAminoglycoside Antibacterial18.1%Neomycin-Polymyxin-Dexameth97%Neomycin-Bacitracin-Polymyxin4%Part D≥266 patients+ 5 more classes in this area
Cardiovascular
9.4%Beta blocker9.4%Timolol Maleate100%Part D≥80 patientsRespiratory
3.3%Opioid Agonist3.3%Hydrocodone-Acetaminophen100%Part D≥90 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2016–2021 per NIH RePORTER. The latest:
- Goldmann Contact Tonometry with Optimized Error Correction
Cats Tonometer, Llc
FY2021$119,457R44EY026821 - Goldmann Contact Tonometry with Optimized Error Correction
Cats Tonometer, Llc
FY2020$576,827R44EY026821 - Goldmann Contact Tonometry with Optimized Error Correction
Cats Tonometer, Llc
FY2019$428,670R44EY026821
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Enhancing Lipid Detection and Spatial Accuracy in Carotid Plaques Using Mass Spectrometry Imaging Techniques
bioRxiv (Cold Spring Harbor Laboratory)
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Alpert, MD
University of Arizona
Karl Kern, MD
University of Arizona
Peter Reaven, MD
University of Arizona
Alison Stopeck, MD
University of Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”